Guannan Su Selected Research

Autoimmune Diseases (Autoimmune Disease)

11/2023	Identification of FCER1G as a cyclosporin A plus corticosteroid sensitization gene in female patients with Vogt-Koyanagi-Harada disease.
1/2023	TET2-mediated upregulation of 5-hydroxymethylcytosine in LRRC39 promoter promotes Th1 response in association with downregulated Treg response in Vogt-Koyanagi-Harada disease.
1/2023	Genetic association of PRKCD and CARD9 polymorphisms with Vogt-Koyanagi-Harada disease in the Chinese Han population.
1/2021	Meta-Analysis of miRNA Variants Associated with Susceptibility to Autoimmune Disease.
1/2021	Analyses of circRNA and mRNA Profiles in Vogt-Koyanagi-Harada Disease.
1/2020	Identification of Ribosomal Protein S4, Y-Linked 1 as a cyclosporin A plus corticosteroid resistance gene.
1/2017	Genetic polymorphisms of C-type lectin receptors in Behcet's disease in a Chinese Han population.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Guannan Su Research Topics

Disease

27	Uveitis 05/2024 - 01/2020
9	Uveomeningoencephalitic Syndrome (Vogt Koyanagi Harada Syndrome) 11/2023 - 01/2018
7	Autoimmune Diseases (Autoimmune Disease) 11/2023 - 01/2017
7	Behcet Syndrome (Behcet's Syndrome) 10/2023 - 01/2017
5	Inflammation (Inflammations) 01/2022 - 01/2018
4	Neoplasms (Cancer) 12/2022 - 02/2012
4	Anterior Uveitis 04/2021 - 01/2018
3	Genetic Predisposition to Disease (Genetic Predisposition) 11/2023 - 01/2021
3	Necrosis 01/2023 - 01/2018
2	Ankylosing Spondylitis 10/2023 - 01/2021
2	Infections 01/2022 - 01/2020
1	COVID-19 01/2023
1	Multifocal Choroiditis 01/2022
1	Blau syndrome 01/2022
1	Congenital Abnormalities (Deformity) 01/2022
1	Neuroinflammatory Diseases 01/2022
1	Arthritis (Polyarthritis) 01/2022
1	Atrophy 01/2022
1	Exanthema (Rash) 01/2022
1	Glaucoma 01/2022
1	Hepatitis 01/2022
1	Hepatitis B 01/2022
1	Papilledema 01/2022
1	Rheumatic Diseases (Rheumatism) 01/2022
1	Epiretinal Membrane (Epiretinal Membranes) 01/2022
1	Choroidal Neovascularization 01/2022
1	Tuberculosis (Tuberculoses) 04/2021
1	Retinal Vasculitis 03/2021
1	Encephalomyelitis (Myeloencephalitis) 01/2021
1	Type 2 Diabetes Mellitus (MODY) 01/2021
1	Vitamin D Deficiency 01/2021
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 10/2020

Drug/Important Bio-Agent (IBA)

6	CytokinesIBA 01/2024 - 01/2020
5	Retinaldehyde (Retinal)IBA 11/2023 - 07/2020
5	Cyclosporine (Ciclosporin)FDA LinkGeneric 11/2023 - 01/2020
5	Messenger RNA (mRNA)IBA 01/2023 - 01/2018
4	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2023 - 01/2020
3	RNA (Ribonucleic Acid)IBA 05/2024 - 01/2019
3	Proteins (Proteins, Gene)FDA Link 01/2024 - 02/2013
3	Prednisone (Sone)FDA LinkGeneric 09/2022 - 03/2021
3	Biomarkers (Surrogate Marker)IBA 04/2021 - 01/2020
3	Interleukin-17 (Interleukin 17)IBA 01/2021 - 01/2018
2	InterferonsIBA 05/2024 - 01/2020
2	HLA-A*26 antigenIBA 11/2023 - 01/2022
2	Oxidoreductases (Dehydrogenase)IBA 10/2023 - 01/2021
2	Peptides (Polypeptides)IBA 01/2023 - 07/2020
2	MicroRNAs (MicroRNA)IBA 01/2023 - 01/2021
2	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 01/2018
2	Long Noncoding RNAIBA 12/2022 - 11/2019
2	Fluorescein (Funduscein)FDA LinkGeneric 01/2022 - 03/2021
2	Circular RNAIBA 01/2021 - 01/2019
1	4-octyl itaconateIBA 01/2024
1	HLA Antigens (Human Leukocyte Antigens)IBA 11/2023
1	Succinic Acid (Succinate)IBA 11/2023
1	HLA-B51 AntigenIBA 11/2023
1	HLA-B15 AntigenIBA 11/2023
1	Interleukin-8 (Interleukin 8)IBA 10/2023
1	Mitogen-Activated Protein KinasesIBA 10/2023
1	NADP (NADPH)IBA 10/2023
1	5-hydroxymethylcytosineIBA 01/2023
1	Protein Kinase C-deltaIBA 01/2023
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2023
1	ImmunosorbentsIBA 01/2023
1	Adalimumab (Humira)FDA Link 01/2023
1	EnzymesIBA 01/2023
1	Adenosine Triphosphate (ATP)IBA 12/2022
1	MineralsIBA 12/2022
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 12/2022
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 12/2022
1	CarbonIBA 12/2022
1	Air Pollutants (Pollutants, Air)IBA 10/2022
1	antineoplaston A10 (A 10)IBA 10/2022
1	Bevacizumab (Avastin)FDA Link 01/2022
1	Ranibizumab (Lucentis)FDA Link 01/2022
1	ProgranulinsIBA 01/2022
1	ChromatinIBA 01/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022
1	EndotoxinsIBA 01/2022
1	Fluocinolone Acetonide (Capex)FDA LinkGeneric 01/2022
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2022
1	LipopolysaccharidesIBA 01/2022
1	LuciferasesIBA 01/2022
1	NucleotidesIBA 01/2022
1	Triamcinolone Acetonide (Azmacort)FDA LinkGeneric 01/2022
1	Triglycerides (Triacylglycerol)IBA 01/2022
1	Linoleic Acid (Linoleate)IBA 04/2021
1	oxidized low density lipoproteinIBA 01/2021
1	Amino Acids FDA Link 01/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2021
1	Vitamin D FDA LinkGeneric 01/2021
1	Coenzyme A (CoA)IBA 01/2021
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021
1	LDL CholesterolIBA 01/2021
1	Interleukin-23 (Interleukin 23)IBA 01/2021
1	Toll-Like Receptor 10IBA 10/2020

Therapy/Procedure

4	Therapeutics 01/2023 - 02/2012
1	Biological Therapy 10/2023
1	Transplantation 01/2021
1	Slit Lamp 01/2021